Showing results (381-390 of 475) with videos related to
Sort By:
Pageof 48
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cellsBenjamin Weide, Alexander Martens, Henning Zelba, et al.Geroscience|September 23, 2022
Using blood test parameters to define biological age among older adults: association with morbidity and mortality independent of chronological age validated in two separate birth cohortsJohanna Drewelies, Gizem Hueluer, Sandra Duezel, et al.Cancer Immunology Research|June 8, 2014
Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responsesBenjamin Weide, Thomas K Eigentler, Annette Pflugfelder, et al.Cancer Immunology, Immunotherapy : CII|December 14, 2004
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosityTeresa Rodriguez, Rosa Méndez, Chrissy H Roberts, et al.European Journal of Immunology|October 4, 2020
Human pregnancy levels of estrogen and progesterone contribute to humoral immunity by activating TFH /B cell axisClarice Monteiro, Taissa Kasahara, Priscila M Sacramento, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 10, 2012
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunctionJosé G Montoya, Michael N Neely, Sudhir Gupta, et al.Advances in Experimental Medicine and Biology|May 11, 2021
Coronavirus: Pure Infectious Disease or Genetic PredispositionFarzaneh Darbeheshti, Hassan Abolhassani, Mohammad Bashashati, et al.Plos One|August 17, 2019
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockadeJonas Bochem, Henning Zelba, Teresa Amaral, et al.Journal for Immunotherapy of Cancer|April 22, 2017
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancerSotirios P Fortis, Michael Sofopoulos, Nectaria N Sotiriadou, et al.Journal for Immunotherapy of Cancer|June 3, 2017
Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancerSotirios P Fortis, Michael Sofopoulos, Nectaria N Sotiriadou, et al.Pageof 48